Open original FDA record ↗Recall record
- FDA identifier
- Z-1843-2014
- Company in FDA record
- BioFire Diagnostics, Inc.
- FDA classification date
- Jun 20, 2014
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
BioFire has identified an increased risk of false positive results when the FilmArray Blood Culture Identification (BCID) Panel is used with bioMrieux BacT/ALERT Standard Anaerobic (SN) blood culture bottles. False positive results have been observed for Pseudomonas aeruginosa and Enterococcus.
Source facts
- Action
- BioFire Diagnostics sent an Urgent Recall/Correction letter on May 28, 2014. Customers were instructed If the BCID Panel is used to test BacT/ALERT SN bottles, positive results for Pseudomonas aeruginosa and Enterococcus should be confirmed by another method prior to reporting the test results. Customer with questions were instructed contact customer support at Support@biofiredx.com or via telephone by dialing 1-800-735-6544 and selecting option 5 for customer support and then option 1 for FilmArray. For questions regarding this recall call 801-736-6354, ext 360.
- Initiated
- 2014-05-27
- Root cause
- Labeling design
- Terminated
- 2014-11-07
- Distribution
- Worldwide Distribution - USA (nationwide) European Union, Hong Kong, and VA.
- Recall number
- Z-1843-2014
- Recall status
- Terminated
- CDRH record ID
- 127466
- FDA classified
- 2014-06-20
- Recall event number
- 68352